View Future GrowthPhosAgro 과거 순이익 실적과거 기준 점검 5/6PhosAgro은 연평균 43.8%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 0.3% 증가했습니다. 매출은 연평균 20.6%의 비율로 증가했습니다. PhosAgro의 자기자본이익률은 73.8%이고 순이익률은 36.2%입니다.핵심 정보43.85%순이익 성장률43.85%주당순이익(EPS) 성장률Chemicals 산업 성장률31.77%매출 성장률20.59%자기자본이익률73.83%순이익률36.17%최근 순이익 업데이트30 Jun 2022최근 과거 실적 업데이트공시 • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024공시 • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024공시 • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.모든 업데이트 보기Recent updates공시 • Mar 21Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025. Location: leninsky prospect 55 1, moscow Russia공시 • Feb 17Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025.공시 • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024공시 • May 31Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024.공시 • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024공시 • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024공시 • Feb 23PhosAgro Global Depositary Receipts - Sponsored to be Deleted from OTC EquityPublic Joint-Stock Company PhosAgro Global Depositary Receipts - Sponsored will be deleted from OTC Equity effective February 22, 2024, due to CUSIP Suspended.Upcoming Dividend • Jul 01Upcoming dividend of ₽390 per shareEligible shareholders must have bought the stock before 08 July 2022. Payment date: 12 July 2022. Payout ratio and cash payout ratio are on the higher end at 88% and 94% respectively. Trailing yield: 11%. Lower than top quartile of Russian dividend payers (12%). Higher than average of industry peers (7.7%).Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Major Estimate Revision • Feb 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from ₽521.8b to ₽497.2b. EPS estimate rose from ₽1,261 to ₽1,831. Net income forecast to grow 66% next year vs 15% growth forecast for Chemicals industry in Russian Federation. Consensus price target down from ₽6,057 to ₽5,501. Share price fell 12% to ₽5,145 over the past week.Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to ₽4,378, the stock trades at a forward P/E ratio of 2x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 128% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₽5,452 per share.Major Estimate Revision • Feb 19Consensus EPS estimates increase by 45%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₽488.8b to ₽527.6b. EPS estimate increased from ₽1,261 to ₽1,831 per share. Net income forecast to shrink 12% next year vs 14% growth forecast for Chemicals industry in Russian Federation . Consensus price target broadly unchanged at ₽5,597. Share price was steady at ₽5,870 over the past week.Major Estimate Revision • Feb 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽416.5b to ₽477.2b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price was steady at ₽5,926 over the past week.Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Feb 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽409.3b to ₽473.3b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price rose 13% to ₽5,936 over the past week.Upcoming Dividend • Dec 10Upcoming dividend of ₽234 per shareEligible shareholders must have bought the stock before 17 December 2021. Payment date: 21 December 2021. Payout ratio is a comfortable 72% and this is well supported by cash flows. Trailing yield: 5.3%. Lower than top quartile of Russian dividend payers (8.2%). Higher than average of industry peers (4.0%).Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.Upcoming Dividend • Sep 16Upcoming dividend of ₽156 per shareEligible shareholders must have bought the stock before 23 September 2021. Payment date: 27 September 2021. Trailing yield: 5.9%. Lower than top quartile of Russian dividend payers (8.1%). Higher than average of industry peers (2.4%).Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Major Estimate Revision • Aug 07Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ₽325.4b to ₽393.0b. EPS estimate unchanged from ₽524 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at ₽4,045. Share price was steady at ₽4,573 over the past week.Upcoming Dividend • Jun 25Upcoming dividend of ₽105 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 06 July 2021. Trailing yield: 6.2%. Lower than top quartile of Russian dividend payers (7.7%). Higher than average of industry peers (4.1%).Upcoming Dividend • May 28Upcoming dividend of ₽63.00 per shareEligible shareholders must have bought the stock before 04 June 2021. Payment date: 08 June 2021. Trailing yield: 6.4%. Lower than top quartile of Russian dividend payers (8.0%). Higher than average of industry peers (4.3%).Reported Earnings • May 21First quarter 2021 earnings released: EPS ₽142 (vs ₽120 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₽87.6b (up 37% from 1Q 2020). Net income: ₽18.4b (up ₽33.9b from 1Q 2020). Profit margin: 21% (up from net loss in 1Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Feb 20Full year 2020 earnings released: EPS ₽131 (vs ₽381 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₽253.9b (up 2.3% from FY 2019). Net income: ₽16.9b (down 66% from FY 2019). Profit margin: 6.7% (down from 20% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Feb 20Revenue and earnings miss expectationsRevenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 11%. Over the next year, revenue is forecast to grow 13%, compared to a 3.2% growth forecast for the Chemicals industry in Russia.Is New 90 Day High Low • Feb 15New 90-day high: ₽3,717The company is up 21% from its price of ₽3,084 on 17 November 2020. The Russian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,498 per share.Major Estimate Revision • Feb 10Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽215 to ₽258. Revenue estimate for the same period was approximately flat at ₽260.9b. Net income is expected to grow by 356% next year compared to 25% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽50.69 to ₽47.62. Share price is down by 1.1% to ₽3,622 over the past week.Major Estimate Revision • Nov 08Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽226 to ₽249. Revenue estimate for the same period was approximately flat at ₽255.7b. Net income is expected to grow by 73% next year compared to 13% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽43.38 to ₽43.27. Share price is up 5.5% to ₽2,974 over the past week.Is New 90 Day High Low • Nov 07New 90-day high: ₽2,974The company is up 11% from its price of ₽2,680 on 07 August 2020. The Russian market is down 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽3,489 per share.Is New 90 Day High Low • Sep 28New 90-day high: ₽2,821The company is up 7.0% from its price of ₽2,643 on 30 June 2020. The Russian market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,189 per share.매출 및 비용 세부 내역PhosAgro가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이MISX:PHOR 매출, 비용 및 순이익 (RUB Millions)날짜매출순이익일반관리비연구개발비30 Jun 22580,736210,07443,151031 Mar 22501,164175,86635,631031 Dec 21420,488129,69727,893030 Sep 21351,455100,82558,457030 Jun 21306,14460,31525,453031 Mar 21277,40050,87256,154031 Dec 20253,87916,93224,101030 Sep 20248,13010,64331,812030 Jun 20241,68821,70638,797031 Mar 20239,89612,61045,425031 Dec 19248,12549,34952,699030 Sep 19254,53447,16351,557030 Jun 19252,66845,18850,311031 Mar 19250,97736,35949,895031 Dec 18233,31222,06947,768030 Sep 18219,53921,83145,680030 Jun 18203,30721,40743,003031 Mar 18191,57519,93540,397031 Dec 17181,35125,33338,355030 Sep 17175,70832,44736,930030 Jun 17174,81437,50935,138031 Mar 17176,06749,52034,338031 Dec 16187,74259,88433,367030 Sep 16195,03953,40232,305030 Jun 16198,54944,86032,371031 Mar 16195,77944,90531,016031 Dec 15189,73236,44229,9350양질의 수익: PHOR의 비현금 수익 수준이 높습니다.이익 마진 증가: PHOR의 현재 순 이익률 (36.2%)은 지난해 (19.7%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: PHOR의 수익은 지난 5년 동안 연평균 43.8%로 크게 증가했습니다.성장 가속화: 지난 1년간 PHOR 의 수익 증가율(248.3%)은 연간 평균(43.8%)을 초과합니다.수익 대 산업: PHOR의 지난 1년 수익 증가율(248.3%)은 Chemicals 업계의 -1.3%를 상회했습니다.자기자본이익률높은 ROE: PHOR의 자본 수익률(73.8%)은 뛰어남으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2022/10/05 15:22종가2022/07/08 00:00수익2022/06/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Public Joint-Stock Company PhosAgro는 10명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Edwin CheeBMO Capital Markets Equity ResearchJoel JacksonBMO Capital Markets Equity ResearchSashank LankaBofA Global Research7명의 분석가 더 보기
공시 • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024
공시 • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024
공시 • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024
Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.
Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Mar 21Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025. Location: leninsky prospect 55 1, moscow Russia
공시 • Feb 17Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025.
공시 • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024
공시 • May 31Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024.
공시 • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024
공시 • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024
공시 • Feb 23PhosAgro Global Depositary Receipts - Sponsored to be Deleted from OTC EquityPublic Joint-Stock Company PhosAgro Global Depositary Receipts - Sponsored will be deleted from OTC Equity effective February 22, 2024, due to CUSIP Suspended.
Upcoming Dividend • Jul 01Upcoming dividend of ₽390 per shareEligible shareholders must have bought the stock before 08 July 2022. Payment date: 12 July 2022. Payout ratio and cash payout ratio are on the higher end at 88% and 94% respectively. Trailing yield: 11%. Lower than top quartile of Russian dividend payers (12%). Higher than average of industry peers (7.7%).
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Major Estimate Revision • Feb 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from ₽521.8b to ₽497.2b. EPS estimate rose from ₽1,261 to ₽1,831. Net income forecast to grow 66% next year vs 15% growth forecast for Chemicals industry in Russian Federation. Consensus price target down from ₽6,057 to ₽5,501. Share price fell 12% to ₽5,145 over the past week.
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to ₽4,378, the stock trades at a forward P/E ratio of 2x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 128% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₽5,452 per share.
Major Estimate Revision • Feb 19Consensus EPS estimates increase by 45%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₽488.8b to ₽527.6b. EPS estimate increased from ₽1,261 to ₽1,831 per share. Net income forecast to shrink 12% next year vs 14% growth forecast for Chemicals industry in Russian Federation . Consensus price target broadly unchanged at ₽5,597. Share price was steady at ₽5,870 over the past week.
Major Estimate Revision • Feb 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽416.5b to ₽477.2b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price was steady at ₽5,926 over the past week.
Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Feb 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽409.3b to ₽473.3b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price rose 13% to ₽5,936 over the past week.
Upcoming Dividend • Dec 10Upcoming dividend of ₽234 per shareEligible shareholders must have bought the stock before 17 December 2021. Payment date: 21 December 2021. Payout ratio is a comfortable 72% and this is well supported by cash flows. Trailing yield: 5.3%. Lower than top quartile of Russian dividend payers (8.2%). Higher than average of industry peers (4.0%).
Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.
Upcoming Dividend • Sep 16Upcoming dividend of ₽156 per shareEligible shareholders must have bought the stock before 23 September 2021. Payment date: 27 September 2021. Trailing yield: 5.9%. Lower than top quartile of Russian dividend payers (8.1%). Higher than average of industry peers (2.4%).
Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Major Estimate Revision • Aug 07Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ₽325.4b to ₽393.0b. EPS estimate unchanged from ₽524 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at ₽4,045. Share price was steady at ₽4,573 over the past week.
Upcoming Dividend • Jun 25Upcoming dividend of ₽105 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 06 July 2021. Trailing yield: 6.2%. Lower than top quartile of Russian dividend payers (7.7%). Higher than average of industry peers (4.1%).
Upcoming Dividend • May 28Upcoming dividend of ₽63.00 per shareEligible shareholders must have bought the stock before 04 June 2021. Payment date: 08 June 2021. Trailing yield: 6.4%. Lower than top quartile of Russian dividend payers (8.0%). Higher than average of industry peers (4.3%).
Reported Earnings • May 21First quarter 2021 earnings released: EPS ₽142 (vs ₽120 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₽87.6b (up 37% from 1Q 2020). Net income: ₽18.4b (up ₽33.9b from 1Q 2020). Profit margin: 21% (up from net loss in 1Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Feb 20Full year 2020 earnings released: EPS ₽131 (vs ₽381 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₽253.9b (up 2.3% from FY 2019). Net income: ₽16.9b (down 66% from FY 2019). Profit margin: 6.7% (down from 20% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Feb 20Revenue and earnings miss expectationsRevenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 11%. Over the next year, revenue is forecast to grow 13%, compared to a 3.2% growth forecast for the Chemicals industry in Russia.
Is New 90 Day High Low • Feb 15New 90-day high: ₽3,717The company is up 21% from its price of ₽3,084 on 17 November 2020. The Russian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,498 per share.
Major Estimate Revision • Feb 10Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽215 to ₽258. Revenue estimate for the same period was approximately flat at ₽260.9b. Net income is expected to grow by 356% next year compared to 25% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽50.69 to ₽47.62. Share price is down by 1.1% to ₽3,622 over the past week.
Major Estimate Revision • Nov 08Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽226 to ₽249. Revenue estimate for the same period was approximately flat at ₽255.7b. Net income is expected to grow by 73% next year compared to 13% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽43.38 to ₽43.27. Share price is up 5.5% to ₽2,974 over the past week.
Is New 90 Day High Low • Nov 07New 90-day high: ₽2,974The company is up 11% from its price of ₽2,680 on 07 August 2020. The Russian market is down 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽3,489 per share.
Is New 90 Day High Low • Sep 28New 90-day high: ₽2,821The company is up 7.0% from its price of ₽2,643 on 30 June 2020. The Russian market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,189 per share.